Kurt Nielsen, Ph.D., has been appointed chief technology officer and senior vice president of innovation and growth at Catalent Pharma Solutions, Inc. Dr. Nielsen will be responsible for driving innovation activities and investments across the company’s range of advanced dose forms and packaging technologies. Dr. Nielsen will report to John Chiminski, president and chief executive officer of Catalent, and will be based at the company’s global headquarters in Somerset, NJ. Dr. Nielsen most rec...